VTVT vTv Therapeutics Inc

Price (delayed)

$22.96

Market cap

$69.11M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.48

Enterprise value

$17.16M

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment ...

Highlights
VTVT's equity has soared by 184% since the previous quarter
The quick ratio has soared by 171% YoY
The company's EPS rose by 13% QoQ but it fell by 10% YoY
The net income has declined by 24% year-on-year

Key stats

What are the main financial stats of VTVT
Market
Shares outstanding
3.01M
Market cap
$69.11M
Enterprise value
$17.16M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.32
Price to sales (P/S)
69.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.16
Earnings
Revenue
$1M
EBIT
-$20.5M
EBITDA
-$20.41M
Free cash flow
-$21.25M
Per share
EPS
-$8.48
Free cash flow per share
-$7.06
Book value per share
$6.91
Revenue per share
$0.33
TBVPS
$18
Balance sheet
Total assets
$54.18M
Total liabilities
$28.2M
Debt
$298,000
Equity
$20.8M
Working capital
$44.95M
Liquidity
Debt to equity
0.01
Current ratio
6.04
Quick ratio
5.97
Net debt/EBITDA
2.55
Margins
EBITDA margin
-2,041.3%
Gross margin
100%
Net margin
-2,061.6%
Operating margin
-2,289%
Efficiency
Return on assets
-80.4%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-45.3%
Return on sales
-2,050.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VTVT stock price

How has the vTv Therapeutics stock price performed over time
Intraday
12.55%
1 week
-5.86%
1 month
21.93%
1 year
-19.74%
YTD
99.65%
QTD
30.01%

Financial performance

How have vTv Therapeutics's revenue and profit performed over time
Revenue
$1M
Gross profit
$1M
Operating income
-$22.89M
Net income
-$20.62M
Gross margin
100%
Net margin
-2,061.6%
The operating margin has soared by 98% YoY
VTVT's net margin has surged by 98% year-on-year
The net income has declined by 24% year-on-year
VTVT's operating income is up by 8% QoQ

Growth

What is vTv Therapeutics's growth rate over time

Valuation

What is vTv Therapeutics stock price valuation
P/E
N/A
P/B
3.32
P/S
69.11
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
17.16
The company's EPS rose by 13% QoQ but it fell by 10% YoY
VTVT's equity has soared by 184% since the previous quarter
The P/S is 96% lower than the 5-year quarterly average of 1755.5

Efficiency

How efficient is vTv Therapeutics business performance
The company's return on sales has surged by 98% YoY
vTv Therapeutics's return on assets has shrunk by 62% YoY but it has increased by 23% QoQ

Dividends

What is VTVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VTVT.

Financial health

How did vTv Therapeutics financials performed over time
VTVT's total assets is 92% greater than its total liabilities
The quick ratio has soared by 171% YoY
The current ratio has soared by 150% year-on-year
VTVT's debt is 99% smaller than its equity
VTVT's equity has soared by 184% since the previous quarter
The debt to equity has soared by 150% since the previous quarter and by 150% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.